Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of Calne Ry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calne Ry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calne Ry more than expected).
This network shows the impact of papers produced by Calne Ry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calne Ry. The network helps show where Calne Ry may publish in the future.
Co-authorship network of co-authors of Calne Ry
This figure shows the co-authorship network connecting the top 25 collaborators of Calne Ry.
A scholar is included among the top collaborators of Calne Ry based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Calne Ry. Calne Ry is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Rasmussen, Allan, et al.. (1994). Transplantation of immunomodulated dog islets.. PubMed. 26(2). 754–754.1 indexed citations
2.
Ry, Calne, et al.. (1991). Rapamycin in experimental renal allografts in primates.. PubMed. 23(4). 2246–7.24 indexed citations
3.
Lim, Siong Meng, White Dj, & Calne Ry. (1988). Cyclosporine coverage during the risk period leads to 100% long-term graft acceptance in the rat.. PubMed. 20(3 Suppl 3). 1013–5.2 indexed citations
4.
Ry, Calne. (1986). The current state of renal transplantation.. PubMed. 19. S23–4.1 indexed citations
5.
Rolles, Keith & Calne Ry. (1986). Cyclosporine in the first month posttransplant.. PubMed. 18(2 Suppl 1). 55–8.1 indexed citations
6.
Ry, Calne. (1984). Surgical research--curiosity and luck: personal observations and prejudices.. PubMed. 66(3). 211–3.2 indexed citations
7.
Brons, G & Calne Ry. (1983). Transplantation of the pancreas in man.. PubMed. 81–4.1 indexed citations
Ry, Calne. (1981). The development of immunosuppressive therapy.. PubMed. 13(1 Suppl 1). 44–9.7 indexed citations
10.
Ry, Calne. (1980). Immunosuppression for organ grafting.. PubMed. 12(2). 2175–43.5 indexed citations
11.
McMaster, P, et al.. (1980). Pancreatic transplantation in man.. PubMed. 12(4 Suppl 2). 58–61.7 indexed citations
12.
Ry, Calne, et al.. (1980). Technical observations in segmental pancreas allografting: observations on pancreatic blood flow.. PubMed. 12(4 Suppl 2). 51–7.27 indexed citations
13.
Ry, Calne, White Dj, Keith Rolles, et al.. (1979). Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants.. PubMed. 11(1). 860–4.37 indexed citations
14.
Marni, A, Philip D. McMaster, Evans Db, & Calne Ry. (1979). Is it really worth re-transplanting patients?. PubMed. 16. 352–8.3 indexed citations
15.
Ry, Calne. (1977). Some personal observations on the university department of surgery.. PubMed. 59(2). 158–9.2 indexed citations
16.
Ry, Calne, et al.. (1976). Orthotopic heart transplantation in the pig: the pattern of rejection.. PubMed. 8(1). 27–30.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.